Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04149249 · ClinicalTrials.gov registry record · NA
CONNECT: Smoking Cessation and Lung Cancer Screening
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT04149249: Completed NA study, sponsored by University of California, San Francisco.
NCT04149249 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04149249, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
This clinical trial studies the impact of CONNECT on biochemically confirmed smoking abstinence among diverse current smokers who are undergoing lung cancer screening.
Primary Outcome
Biochemically confirmed 30-day smoking abstinence at 3 months post lung cancer screening.
Interventions
- OTHER Computer-Assisted Intervention Video Doctor
- OTHER Computer-Assisted Intervention no Video Doctor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2019-08-21 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
What the finished NCT04149249 record still lists
NCT04149249 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Computer-Assisted Intervention Video Doctor is the first listed.
NCT04149249 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04149249 about?
NCT04149249 is a clinical study titled "CONNECT: Smoking Cessation and Lung Cancer Screening". This clinical trial studies the impact of CONNECT on biochemically confirmed smoking abstinence among diverse current smokers who are undergoing lung cancer screening.
What is the current status of trial NCT04149249?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2019-08-21. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT04149249?
The interventions under investigation include: Computer-Assisted Intervention Video Doctor (OTHER), Computer-Assisted Intervention no Video Doctor (OTHER).
Who is sponsoring clinical trial NCT04149249?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04149249's enrollment target sits among peer trials
99 920th of 2000 higher than 1,079 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI